Susceptibility testing of herpes viruses

Area of Science:

• Virology
• Clinical Microbiology
• Infectious Diseases

Background:

• The plaque reduction or cytopathic effect (CPE) assay is a standard method for virus sensitivity testing in research and clinical settings.
• Recent years have seen significant methodological advancements in these virus detection procedures.
• However, a critical gap exists in understanding the correlation between virus sensitivity and clinical outcomes.

Purpose of the Study:

• To review the current state of virus sensitivity testing methodologies.
• To assess the availability of data correlating virus sensitivity with clinical outcomes.
• To identify the need for further research into the clinical relevance of virus sensitivity assays.

Main Methods:

• Review of existing literature on virus sensitivity testing.
• Analysis of studies reporting on the correlation between in vitro virus sensitivity and clinical response.
• Evaluation of methodological changes in plaque reduction and CPE assays.

Main Results:

• Virus sensitivity testing methods have evolved significantly.
• Data directly correlating virus sensitivity with clinical outcomes remains limited.
• Available data suggests a lack of direct correlation between virus sensitivity and clinical response.

Conclusions:

• Despite methodological advancements, a clear link between virus sensitivity and clinical outcomes is not established.
• Further research is required to define optimal parameters for correlating virus sensitivity assays with patient responses.
• The clinical utility of current virus sensitivity testing in predicting treatment success needs further investigation.